The cytoplasmic enzyme glycerophosphate dehydrogenase (GPD) plays a pivotal role in lipid synthesis and fuel metabolism in a number of tissues. Our overall objective is to delineate the molecular processes which activate and modulate the expression of the specific gene encoding GPD in skeletal muscle. Towards this goal we have already demonstrated the responsiveness of chimeric GPD genes in myogenic cell lines, which represents the first successful regulation of appropriate GPD expression in vitro. We have now identified by deletional analysis a 1 kb intragenic region downstream from the GPD promoter which confers differentiation-dependent expression on an attached reporter gene in mouse C2-skeletal muscle cells. This DNA segment will be further dissected to localize sequences that specifically activate GPD late in the myogenic program. Our recent studies suggest that GPD regulation involves a novel myoblast silencer plus a muscle-specific enhancer, distinct from characterized muscle enhancers. To elucidate the mechanism of GPD activation, we will use in vitro binding and footprinting assays and site-directed mutagenesis of GPD regulatory sequences to define nuclear factor binding sites, their differentiation-dependent usage, and the profile of nuclear proteins that interact with them. Similarly, the DNA sequences and trans-acting factors which mediate inhibition by two catabolic agents, cyclic AMP-linked lipolytic hormones and tumor necrosis factor (the active agent of cachexia), will be characterized. Novel DNA- binding regulatory factors that control GPD expression will be isolated from cDNA expression libraries. We describe a new strategy, using chimeric c-fos/GPD constructs, to delineate the molecular basis for insulin stimulation of GPD transcription and GPD mRNA stability. Finally, we will determine the pattern of GPD expression in different muscle fibers and how disease-related states that affect insulin responsiveness in skeletal muscle (denervation, high fat feeding, genetic obesity) affect GPD expression in vivo. These experiments should yield novel insights into the mechanisms by which metabolic gene expression is regulated in skeletal muscle during development and in response to hormonal controls.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Karagiannides, I; Tchkonia, T; Dobson, D E et al. (2001) Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol 280:R1772-80
Kirkland, J L; Dobson, D E (1997) Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function. J Am Geriatr Soc 45:959-67
Stephens, J M; Lee, J; Pilch, P F (1997) Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272:971-6
Kandror, K V; Pilch, P F (1996) The insulin-like growth factor II/mannose 6-phosphate receptor utilizes the same membrane compartments as GLUT4 for insulin-dependent trafficking to and from the rat adipocyte cell surface. J Biol Chem 271:21703-8
Engert, J C; Berglund, E B; Rosenthal, N (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 135:431-40
Stephens, J M; Morrison, R F; Pilch, P F (1996) The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 271:10441-4
Coderre, L; Vallega, G A; Pilch, P F et al. (1996) In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol 271:E643-8
Kandror, K V; Pilch, P F (1996) Compartmentalization of protein traffic in insulin-sensitive cells. Am J Physiol 271:E1-14
Milasincic, D J; Calera, M R; Farmer, S R et al. (1996) Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol Cell Biol 16:5964-73
Reginelli, A D; Wang, Y Q; Sassoon, D et al. (1995) Digit tip regeneration correlates with regions of Msx1 (Hox 7) expression in fetal and newborn mice. Development 121:1065-76

Showing the most recent 10 out of 19 publications